Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Full-Life Technologies Completes $37 Million (USD) Series A Financing to Accelerate Development of its Radiopharmaceutical Pipeline and Radiotechnology Production Platform
Full-Life Technologies (“Full-Life”) today announced it completed a $37 million (USD) Series A financing round to advance […]
Novavax Announces Participation in Oxford University Com-COV3 Booster Trial of COVID-19 Vaccines in Adolescents Aged 12 Through
Novavax is participating in a stage of the COVID-19 Vaccine Schedule Combinations (Com-COV) program initiated by the […]
RemedyBio Introduces Scientific Advisory Board
RemedyBio, a biotech company pioneering its proprietary ultra-high throughput single cell Nanoreactor™ platform for discovery […]
Roche Develops Unique PCR Tests to Detect the Monkeypox Virus
Roche (SIX: RO, ROG; OTCQX: RHHBY) and its subsidiary TIB Molbiol have developed three unique LightMix® Modular Virus […]
NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment
NuvoAir’s Asthma Assessment Service uses respiratory physiologists and connected, award-winning home monitoring technology, such as […]
Spending Less Time Watching TV Could Cut Coronary Heart Disease Risk
Watching too much TV is associated with an increased risk of coronary heart disease regardless […]
Invenio Imaging Receives CE Mark to Detect Cancer at the Time of Surgery using Artificial Intelligence
Invenio Imaging, the leader in intraoperative fresh tissue imaging, announced today the CE Mark for […]
inHEART Receives FDA Clearance for Novel 3D Cardiac Modeling Solution
inHEART, a privately-held medical device company delivering the world’s most sophisticated digital twin of the […]
FUJIFILM Cellular Dynamics Launches Parkinson’s Disease iCell DopaNeurons featuring LRRK2 and GBA Mutations
FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem […]
KaliVir Immunotherapeutics Enters into Global Exclusive Licensing Agreement with Roche for Novel Oncolytic Viruses
KaliVir Immunotherapeutics, Inc. today announced a collaboration and global exclusive licensing agreement with Roche for […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more